UNCLAIMED
simulations plus
Overview
Simulations Plus, based in the USA, operates within the Computers and Technology industry, specifically focusing on information technology and computer software. With a workforce of 243 employees and reported revenues of approximately $70 million, the company specializes in providing advanced software solutions for drug development. A notable aspect of their offerings includes training workshops, such as the introductory population pharmacokinetic (PK) data analysis workshop utilizing NONMEM, a software tool widely used in pharmacometric modeling. This workshop is designed to impart both theoretical knowledge and practical skills necessary for implementing population PK methodologies in drug development programs. Participants, regardless of their prior experience, engage in hands-on exercises that include coding, model evaluation, and compliance with regulatory guidelines from the FDA and EMA. The workshop aims to enhance the effectiveness of study designs through accurate data collection and analysis, thereby supporting the overall drug development process. The company’s focus on education and practical application underscores its commitment to advancing methodologies in pharmacokinetics and drug development.